HOME >> MEDICINE >> NEWS
Study shows drugs such as Vioxx and Celebrex were widely over-used long before recent problems

Even before making the connection between drugs such as Vioxx and heart attacks, many doctors were becoming concerned that the heavily advertised drugs known as COX-2 inhibitors were being over-used, often by patients unlikely to benefit from this costly but innovative pharmaceutical class.

In the January 25, 2005, issue of the Archives of Internal Medicine, researchers from the University of Chicago and Stanford University School of Medicine use data from the National Center for Health Statistics to show that most of the growth in COX-2 use between 1999 and 2002 occurred in patients at little risk for side effects from the drugs COX-2s were developed to replace.

"We found a rapid nationwide shift away from older, inexpensive drugs with better established safety and efficacy to newer, costly drugs with no real history," said study author G. Caleb Alexander, M.D., M.S., instructor of medicine and a member of the MacLean Center for Clinical Medical Ethics at the University of Chicago.

"We pursued our analysis because of concerns that this was an example of overuse of a newer, more expensive class of medications," said co-author Randall S. Stafford, M.D., Ph.D., associate professor and Director of the Program on Prevention Outcomes and Practice at Stanford University. "As with other examples in the treatment of high blood pressure, diabetes and some infections, there appears to be a tendency for new drugs to be used in a wider array of situations than supported by scientific studies."

The COX-2 inhibitors, introduced early in 1999, were widely promoted as "super aspirin." Ordinary aspirin blocks both COX-2, which triggers inflammation, as well as COX-1, which protects the stomach lining and helps to decrease the risk of GI bleeds and stomach ulcers. These newer and far more expensive drugs were designed to target only COX-2 and to be used to treat patients with chronic inflammatory disorders such as arthritis.

The C
'"/>

Contact: John Easton
John.Easton@uchospitals.edu
773-702-6241
University of Chicago Medical Center
21-Jan-2005


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... ... September 21, 2018 , ... Liz Dudek, Director of Health Care ... Hillsborough County Chapter meeting of the Florida Assisted Living Association (FALA) at 10:00 a.m. ... Dudek’s presentation will provide an overview of the success of the first five years ...
(Date:9/22/2018)... , ... September 22, 2018 , ... ... In fact, there are actually 29 different categories listed in section 501(c) of ... or religious organizations (often referred to as a 501(c)(3)), private foundations, political organizations, ...
(Date:9/15/2018)... ... September 14, 2018 , ... ... other funding, full FY 2019 appropriations for Labor, Health and Human Services and ... the evidence-based Teen Pregnancy Prevention (TPP) Program, and $286.5 million for the Title ...
(Date:9/12/2018)... ... 2018 , ... De Novo Strategies for Getting Your Medical Device Approved:, What ... p.m. – 3:00 p.m. ET, http://www.fdanews.com/denovostrategies , What’s the best route ... , What are the best practices to win approval? , These are some of ...
(Date:9/12/2018)... ... September 13, 2018 , ... Glori Blends will be attending the ... , The expo will include vendors, presentations, panel discussions and a special pavilion for ... on their award winning products and assist customers with the best selection for their ...
Breaking Medicine News(10 mins):
(Date:9/7/2018)... , ... September 06, 2018 , ... This year, the ... Paper Award for his presentation of: IDEAL IMPLANT® - Seven-Year Clinical Trial Results at ... the paper again at the upcoming ASPS (American Society of Plastic Surgeons) meeting in ...
(Date:9/7/2018)... ... September 07, 2018 , ... New York City is ... the globe gather in hopes of claiming the fourth and final jewel in the ... sizzling serves and vicious volleys. Seldom, however, will the players’ footwork be highlighted. , ...
(Date:9/3/2018)... ... September 03, 2018 , ... ... residents with more than 1,200 residents and 200 fellows for the 2018-2019 academic ... in the nation. Charleston area institutions such as McLeod Health, MUSC Health, Tidelands ...
Breaking Medicine Technology:
Cached News: